Seast­ead­er, drug lib­er­tar­i­an and now FDA Com­mis­sion­er? Pe­ter Thiel backs a rad­i­cal shift

Once Bloomberg broke the word that Pe­ter Thiel as­so­ciate Jim O’Neill was be­ing con­sid­ered for the top job at the FDA, re­porters start­ed to nose out the most out­ra­geous re­marks had made. And there are some doozies.

The busi­ness news ser­vice start­ed out with the most rel­e­vant: O’Neill has called for a new sys­tem that would ap­prove drugs that es­tab­lish a base­line on safe­ty, let­ting con­sumers sort out the ef­fi­ca­cy side of thing.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.